Advancing Therapies for Patients
Sarah Cannon Research Institute
Be the first to know the next treatment option for colorectal cancer.
Participating in a clinical trial is the first step in fighting colorectal cancer, not the last. That’s why it’s so important to know your options. As a leader in cancer research, Sarah Cannon Research Institute is on a journey to discover new medication and device treatments for colorectal cancer. Participating in a clinical trial allows you access to the most cutting-edge treatments available and ultimately may lead to developing new standards of care that are safer and more effective. The first step is yours. We’ll be with you the rest of the way. Learn more about our current colorectal cancer clinical trials by clicking here.
askSARAH
Talk to your physician about participating in a colorectal cancer clinical trial or askSARAH (toll-free) at 1-877-691-7274.
Our News
View All News-
SCRI in the News
April 12, 2012
-
Nashville woman's cancer fight inspiring thousands
March 26, 2012
NASHVILLE, TN (WSMV) - Her's was a bleak situation. A young Nashville mom's third child was stillborn, then, to make matters worse, the woman was diagnosed with stage four colon cancer.
-
Collaborating to Provide Comprehensive Cancer Care
March 22, 2012
A discussion between primary care providers and the oncology multidisciplinary team” event - also known as Oncology 101. The event is a CME program for Primary Care Physicians and advanced practitioners to learn more about oncology care.
Community Based Research
-
SCRI Locations
- More than 700 physicians
- Multiple therapeutic areas
- United Kingdom and Global Services -
Scientific Excellence
Nine Physicians Associated with Sarah Cannon Research Institute Named to Best Doctors List
Digg
Del.icio.us
Yahoo
Google
Newsvine